Development and initial testing of the stroke rapid-treatment readiness tool

DaiWai M Olson; Margueritte Cox; Mark Constable; Gavin W Britz; Cheryl B Lin; Louise O Zimmer; Gregg C Fonarow; Lee H Schwamm; Eric D Peterson

doi:10.1097/JNN.0000000000000082

Development and initial testing of the stroke rapid-treatment readiness tool

J Neurosci Nurs. 2014 Oct;46(5):267-73. doi: 10.1097/JNN.0000000000000082.

Authors

DaiWai M Olson¹, Margueritte Cox, Mark Constable, Gavin W Britz, Cheryl B Lin, Louise O Zimmer, Gregg C Fonarow, Lee H Schwamm, Eric D Peterson

Affiliation

¹ Questions or comments about this article may be directed to DaiWai M. Olson, PhD RN CCRN, at DaiWai.Olson@UTSouthwestern.edu. He is an Associate Professor of Neurology and Neurotherapeutics at the University of Texas Southwestern Medical Center, Dallas, TX. Margueritte Cox, MS, is a Biostatistician at Duke Clinical Research Institute, Durham, NC. Mark Constable, RN, is a Stroke Coordinater at Duke Clinical Research Institute and Duke University, Durham, NC. Gavin W. Britz, MD, is a Professor of Neurosurgery and the Chairman of Neurosurgery at Methodist Hospital, Houston, TX. Cheryl B. Lin, MD, is a Medical Resident at Duke Clinical Research Institute and Duke University, Durham, NC. Louise O. Zimmer, MPH, is a Clinical Research Coordinator at University of North Carolina at Chapel Hill, Chapel Hill, NC. Gregg C. Fonarow, MD, is a Professor of Medicine and Associate Chief of Cardiology at University of California Los Angeles, Los Angeles, CA. Lee H. Schwamm, MD, is a Professor of Neurology at Harvard University and Vice Chairman of Neurology at Massachusetts General Hospital, Boston, MA. Eric D. Peterson, MD MPH, is a Professor of Medicine at Duke Clinical Research Institute and Duke University, Durham, NC.

Abstract

No instruments are currently available to help health systems identify target areas for reducing door-to-needle times for the administration of intravenous tissue plasminogen activator to eligible patients with ischemic stroke. A 67-item Likert-scale survey was administered by telephone to stroke personnel at 252 U.S. hospitals participating in the "Get With The Guidelines-Stroke" quality improvement program. Factor analysis was used to refine the instrument to a four-factor 29-item instrument that can be used by hospitals to assess their readiness to administer intravenous tissue plasminogen activator within 60 minutes of patient hospital arrival.

Publication types

Research Support, U.S. Gov't, P.H.S.

MeSH terms

Cerebral Infarction / nursing*
Cerebral Infarction / therapy
Early Medical Intervention / organization & administration*
Efficiency, Organizational
Guideline Adherence*
Humans
Infusions, Intravenous
Patient Admission
Patient Care Team / organization & administration
Quality Improvement
Thrombolytic Therapy / nursing*
Time and Motion Studies
Tissue Plasminogen Activator / administration & dosage*
Workflow

Substances

Tissue Plasminogen Activator

Abstract

Publication types

MeSH terms

Substances

Grants and funding